Press Releases 

Helomics® Corporation and MDNA Life Sciences, Inc. Announce the Commercial Launch of MDNA Life Scien

Specimen testing is now commercially available in the clinical laboratories of Helomics Corporation PITTSBURGH AND WEST PALM BEACH– May 11, 2017 - Helomics® Corporation (Helomics), a privately-held, healthcare company providing personalized medicine solutions for clients in the pharmaceutical, diagnostic, and biotechnology industries, and MDNA Life Sciences, Inc. (MDNA), the molecular diagnostics company pioneering the development of liquid biopsy tests based on the mitochondrial genome, today announced the commercial launch of MDNA’s liquid biopsy Prostate Mitomic Test™ (PMT™) in selected U.S. markets. This proprietary test, which utilizes MDNA’s Mitomic Technology™ platform, exploits the

Archive
 Follow Us
  • LinkedIn Social Icon
  • Facebook Basic Square
  • Twitter Basic Square

© 2020 Helomics Corp. All rights reserved.

  • White Twitter Icon
  • Facebook - White Circle
  • White LinkedIn Icon